Your search history is turned on.
Date: February 21, 2024 Jurisdictions: Alberta, British Columbia
_ 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Terrylene Penstock, Chief Financial Officer, of Mantra Pharma Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Mantra Pharma Inc. (the issuer) for the interi...
_ 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Rajinder Chowdhry, Chief Executive Officer, of Mantra Pharma Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Mantra Pharma Inc. (the issuer) for the interim...
MANTRA PHARMA INC. Management Discussion and Analysis FOR THE THREE MONTHS ENDED DECEMBER 31, 2023 MANTRA PHARMA INC. Management Discussion and Analysis For the three months ended on December 31, 2023 1 Introduction This Management Discussion and Analysis (...
GLOBAL SORTWEB MANTRA PHARMA INC. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED DECEMBER 31, 2023 AND 2022 (Expressed in Canadian dollars) (UNAUDITED PREPARED BY MANAGEMENT) 2 MANTRA PHARMA INC. NOTICE OF NO AUDITOR REVIEW OF CONDENSED INTERIM CONSOLIDATED ...
Date: February 14, 2024 Jurisdictions: Alberta, British Columbia
Mantra Pharma - Statement of Executive Compenstion as at September 30 2022 (D0461041.DOCX;4) MANTRA PHARMA INC. 6153 Glendalough Place Vancouver, BC V6N 1S5 Tel: (604) 765-2030 Form 51-102F6V STATEMENT OF EXECUTIVE COMPENSATION Summary Compensation Table The following disclosure (presented in accordance wi...
Date: January 22, 2024 Jurisdictions: Alberta, British Columbia
1 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, Terrylene Penstock, Chief Financial Officer of Mantra Pharma Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and informat...
1 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, Rajinder Chowdhry, Chief Executive Officer of Mantra Pharma Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and informati...
MANTRA PHARMA INC. Management Discussion and Analysis FOR THE YEAR ENDED SEPTEMBER 30, 2023 MANTRA PHARMA INC. Management Discussion and Analysis For the year ended on September 30, 2023 1 Introduction This Management Discussion and Analysis (MD&A) of Mantra ...
Date: January 22, 2024 Jurisdictions: Alberta
Create participation fee form FORM 13-501F2 CLASS 2 REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, CHOWDHRY, Rajinder, an officer of the reporting issuer noted below have examined this Form 13-50 1F2 (the Form) being submitted hereunder to the Alberta Securities Commission and certify that to my k nowledge, having exercised reasonable diligence, ...
GLOBAL SORTWEB MANTRA PHARMA INC. CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED SEPTEMBER 30, 2023 AND 2022 (Expressed in Canadian dollars) INDEPENDENT AUDITORS REPORT To the Shareholders and Directors of Mantra Pharma Inc. Opinion We have audited the consolidated financial statement...